THE ROLE OF ADAPTATION IN ALLOGRAFT ACCEPTANCE

被引：14

作者：

KOENE, RAP

HARRINGTON, JT

HAYRY, P

VANES, LA

BUHLER, F

DEHEER, E

机构：

[1] UNIV HOSP NIJMEGEN, DIV NEPHROL, NIJMEGEN, NETHERLANDS

[2] NEWTON WELLESLEY HOSP, MED, NEWTON LOWER FALLS, MA 02162 USA

[3] SUNY STONY BROOK, MED, STONY BROOK, NY 11794 USA

[4] UNIV HELSINKI, TRANSPLANTAT SURG & IMMUNOL, SF-00100 HELSINKI 10, FINLAND

[5] STATE UNIV LEIDEN, DEPT NEPHROL, 2312 AV LEIDEN, NETHERLANDS

[6] UNIV HOSP BASEL, HYPERTENS UNIT, CH-4031 BASEL, SWITZERLAND

[7] STATE UNIV GRONINGEN, DIV IMMUNOPATHOL, 9700 AB GRONINGEN, NETHERLANDS

[8] STATE UNIV LEIDEN, DEPT PATHOL, 2312 AV LEIDEN, NETHERLANDS

[9] HOP TENON, INSERM, F-75970 PARIS 20, FRANCE

来源：

KIDNEY INTERNATIONAL | 1989年 / 35卷 / 04期

关键词：

D O I：

10.1038/ki.1989.92

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1073 / 1086

页数：14

共 76 条

[41]

KOENE RAP, 1973, J IMMUNOL, V111, P520

[42]

KRAMER P, 1984, LANCET, V1, P989

[43] PREDISPOSITION TO HYPERTENSION AND SUSCEPTIBILITY TO RENAL-DISEASE IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].

KROLEWSKI, AS ;

CANESSA, M ;

WARRAM, JH ;

LAFFEL, LMB ;

CHRISTLIEB, AR ;

KNOWLER, WC ;

RAND, LI .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (03) :140-145

[44] PROLONGATION OF ISLET ALLOGRAFT SURVIVAL FOLLOWING INVITRO CULTURE (24-DEGREES-C) AND A SINGLE INJECTION OF ALS [J].

LACY, PE ;

DAVIE, JM ;

FINKE, EH .

SCIENCE, 1979, 204 (4390) :312-313

[45] INDUCTION OF REJECTION OF SUCCESSFUL ALLOGRAFTS OF RAT ISLETS BY DONOR PERITONEAL-EXUDATE CELLS [J].

LACY, PE ;

DAVIE, JM ;

FINKE, EH .

TRANSPLANTATION, 1979, 28 (05) :415-420

[46] THYROID ALLOGRAFT IMMUNOGENICITY IS REDUCED AFTER A PERIOD IN ORGAN-CULTURE [J].

LAFFERTY, KJ ;

COOLEY, MA ;

WOOLNOUGH, J ;

WALKER, KZ .

SCIENCE, 1975, 188 (4185) :259-261

[47] RESTORATION OF IMMUNOGENICITY TO PASSENGER CELL-DEPLETED KIDNEY ALLOGRAFTS BY THE ADDITION OF DONOR STRAIN DENDRITIC CELLS [J].

LECHLER, RI ;

BATCHELOR, JR .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (01) :31-41

[48]

LEMS SPM, 1981, J IMMUNOL, V127, P665

[49]

LU CY, 1984, J IMMUNOL, V132, P1722

[50]

MARKER SC, 1981, SURGERY, V89, P660

← 1 2 3 4 5 6 7 8 →